@article {Barlev-Gross2021.03.08.21253148, author = {Moria Barlev-Gross and Shay Weiss and Amir Ben-Shmuel and Assa Sittner and Keren Eden and Noam Mazuz and Itai Glinert and Elad Bar-David and Reut Puni and Sharon Amit and Or Kriger and Ofir Schuster and Ron Alcalay and Efi Makdasi and Eyal Epstein and Tal Noy-Porat and Ronit Rosenfeld and Hagit Achdout and Ohad Mazor and Tomer Israely and Haim Levy and Adva Mechaly}, title = {Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens}, elocation-id = {2021.03.08.21253148}, year = {2021}, doi = {10.1101/2021.03.08.21253148}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Public health experts emphasize the need for quick, point-of-care SARS-CoV-2 detection as an effective strategy for controlling virus spread. To this end, many {\textquotedblleft}antigen{\textquotedblright} detection devices were developed and commercialized. These devices are mostly based on detecting SARS-CoV-2{\textquoteright}s nucleocapsid protein. Recently, alerts issued by both the FDA and the CDC raised concerns regarding the devices{\textquoteright} tendency to exhibit false positive results. In this work we developed a novel alternative spike-based antigen assay, comprised of four high-affinity, specific monoclonal antibodies, directed against different epitopes on the spike{\textquoteright}s S1 subunit. The assay{\textquoteright}s performance was evaluated for COVID-19 detection from nasopharyngeal swabs, compared to an in-house nucleocapsid-based assay, composed of antibodies directed against the nucleocapsid. Detection of COVID-19 was carried out in a cohort of 284 qRT-PCR positive and negative nasopharyngeal swab samples. The time resolved fluorescence (TRF) ELISA spike-assay displayed very high specificity (99\%) accompanied with a somewhat lower sensitivity (66\% for Ct\<25), compared to the nucleocapsid ELISA assay which was more sensitive (85\% for Ct\<25) while less specific (87\% specificity). Despite being out-performed by qRT-PCR, we suggest that there is room for such tests in the clinical setting, as cheap and rapid pre-screening tools. Our results further suggest that when applying antigen detection, one must consider its intended application (sensitivity vs specificity), taking into consideration that the nucleocapsid might not be the optimal target. In this regard, we propose that a combination of both antigens might contribute to the validity of the results.Graphic abstract Schematic representation of sample collection and analysis. The figure was created using BioRender.comCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work received no fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Sheba Medical Center (protocol code 7769-20-SMC, Oct 19th, 2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available}, URL = {https://www.medrxiv.org/content/early/2021/03/11/2021.03.08.21253148}, eprint = {https://www.medrxiv.org/content/early/2021/03/11/2021.03.08.21253148.full.pdf}, journal = {medRxiv} }